Man Group plc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,826,576
-16.2%
147,306
+0.8%
0.03%
-18.2%
Q2 2023$10,538,136
+4.2%
146,160
+6.3%
0.03%
-8.3%
Q1 2023$10,112,146
+33.9%
137,468
+21.6%
0.04%
+33.3%
Q4 2022$7,553,677
-13.8%
113,079
+11.1%
0.03%
-34.1%
Q3 2022$8,766,000
+72.1%
101,800
+78.3%
0.04%
+86.4%
Q2 2022$5,094,000
+898.8%
57,100
+1608.0%
0.02%
+1000.0%
Q1 2021$510,000
-91.8%
3,343
-94.7%
0.00%
-92.6%
Q4 2020$6,252,000
-43.6%
62,865
-46.0%
0.03%
-38.6%
Q3 2020$11,090,000
+130.7%
116,349
+170.7%
0.04%
+83.3%
Q2 2020$4,807,000
+89.5%
42,978
+23.2%
0.02%
+50.0%
Q1 2020$2,537,000
-84.9%
34,892
-78.3%
0.02%
-70.9%
Q4 2019$16,774,000
+61.6%
160,847
+54.3%
0.06%
+41.0%
Q3 2019$10,377,000
-19.7%
104,249
-7.9%
0.04%
-17.0%
Q2 2019$12,927,000
+148.6%
113,246
+173.8%
0.05%
+135.0%
Q1 2019$5,199,000
-45.6%
41,354
-41.2%
0.02%
-52.4%
Q4 2018$9,551,000
-54.1%
70,382
-7.1%
0.04%
-44.7%
Q3 2018$20,791,000
-16.3%
75,742
-36.8%
0.08%
-25.5%
Q2 2018$24,842,000
-8.4%
119,908
-27.0%
0.10%
-17.7%
Q1 2018$27,119,000164,2000.12%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders